Skip to main content

FDA move on e-cigarettes means new risks for Fidelity funds

Fidelity Investments' bet on a privately held maker of e-cigarettes faces new risks after U.S. health regulators on Wednesday said they are considering a ban on flavored versions of the popular "vaping" products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.